David Baltimore

Founder & Chairman at Appia Bio

David Baltimore, PhD, is president emeritus and distinguished professor of biology at California Institute of Technology (Caltech). Dr. Baltimore has been involved in the development of American biotechnology since the 1970s. He has helped found numerous companies, most recently Calimmune and Immune Design, and presently serves on the boards of directors at Regulus Therapeutics and the Broad Institute. He is also a member of numerous scientific advisory boards, including Amgen, the Broad Institute, Ragon Institute, and Regulus. Dr. Baltimore has served as president and chair of the American Association for the Advancement of Science and was named a fellow of the American Association for Cancer Research. In 1975, he was awarded the Nobel Prize in Physiology or Medicine for his research into viral replication that provided the key to understanding the life cycle of retroviruses. He earned his PhD from Rockefeller University.

Timeline

  • Founder & Chairman

    Current role